1. Home
  2. RPRX vs BURL Comparison

RPRX vs BURL Comparison

Compare RPRX & BURL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • BURL
  • Stock Information
  • Founded
  • RPRX 1996
  • BURL 1972
  • Country
  • RPRX United States
  • BURL United States
  • Employees
  • RPRX N/A
  • BURL N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • BURL Department/Specialty Retail Stores
  • Sector
  • RPRX Health Care
  • BURL Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • BURL Nasdaq
  • Market Cap
  • RPRX 14.2B
  • BURL 15.8B
  • IPO Year
  • RPRX 2020
  • BURL 2013
  • Fundamental
  • Price
  • RPRX $31.28
  • BURL $255.06
  • Analyst Decision
  • RPRX Strong Buy
  • BURL Strong Buy
  • Analyst Count
  • RPRX 5
  • BURL 15
  • Target Price
  • RPRX $41.60
  • BURL $323.20
  • AVG Volume (30 Days)
  • RPRX 4.5M
  • BURL 1.4M
  • Earning Date
  • RPRX 05-08-2025
  • BURL 03-06-2025
  • Dividend Yield
  • RPRX 2.81%
  • BURL N/A
  • EPS Growth
  • RPRX N/A
  • BURL 49.14
  • EPS
  • RPRX 1.91
  • BURL 7.80
  • Revenue
  • RPRX $2,263,576,000.00
  • BURL $10,625,782,000.00
  • Revenue This Year
  • RPRX $34.04
  • BURL $11.43
  • Revenue Next Year
  • RPRX $6.10
  • BURL $9.76
  • P/E Ratio
  • RPRX $16.36
  • BURL $32.80
  • Revenue Growth
  • RPRX N/A
  • BURL 9.34
  • 52 Week Low
  • RPRX $24.05
  • BURL $174.64
  • 52 Week High
  • RPRX $34.20
  • BURL $298.89
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 35.96
  • BURL 56.98
  • Support Level
  • RPRX $30.64
  • BURL $230.51
  • Resistance Level
  • RPRX $31.51
  • BURL $250.39
  • Average True Range (ATR)
  • RPRX 0.74
  • BURL 9.86
  • MACD
  • RPRX -0.31
  • BURL 2.22
  • Stochastic Oscillator
  • RPRX 18.29
  • BURL 95.67

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About BURL Burlington Stores Inc.

Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.

Share on Social Networks: